Nuvation Bio Inc. — Director's Dealing 2024

Mar 4, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nuvation Bio Inc. (NUVB)
CIK: 0001811063
Period of Report: 2024-02-29

Reporting Person: Wentworth Kerry (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-29	Stock Option (Right to Buy)	$1.87	A	500000	Acquired	2034-02-27	Class A Common Stock (500000)	Direct

Footnotes

F1: Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.